United Parcel Service Inc vs Viatris Inc — how do they compare? United Parcel Service Inc trades at $94.27 (market cap $80.08B), while Viatris Inc trades at $17.49 (market cap $20.03B). The key difference: United Parcel Service Inc is far larger — about 4× Viatris Inc's market cap, and United Parcel Service Inc pays the higher dividend (6.97%). Which is the better fit depends on your goals — on Pluang, investors hold United Parcel Service Inc for 141 Days and Viatris Inc for 57 Days on average.
| UPS | VTRS | |
|---|---|---|
Market Cap | $80.08B | $20.03B |
Volume | 6,706,833 | 14,109,977 |
Sector | Industrials | Health |
52-Week High | $120.00 | $18.27 |
52-Week Low | $82.87 | $9.74 |
Typical Hold Time | 141 Days | 57 Days |
Enterprise Value | $104.10B | $32.15B |
Dividend Yield | 6.97% | 2.75% |
Signals from Pluang's Aura AI — not financial advice
UPS stock trades at $92.28, down 0.89% amid bearish technical signals and mixed fundamentals. The company maintains strong profitability with 29.66% ROE and has beaten earnings estimates for three consecutive quarters. Recent developments include the launch of UPS Secure Commerce and an exclusive TikTok Shop partnership, while facing headwinds from fuel costs and volume pressures. Analyst consensus remains positive with a $118.67 price target representing 29% upside potential.
The investment case balances attractive valuation metrics (P/E 17.5, P/S 0.89) against declining revenue trends and competitive threats. The 7% dividend yield provides income support, but investors face risks from margin compression and Amazon competition. Wall Street sentiment leans bullish despite recent price weakness, with improving domestic margins seen as the key catalyst.
Viatris (VTRS) trades at $17.49, down 0.29% with a bullish technical signal supported by moving averages and oversold RSI levels. The company shows consistent earnings beats with Q2 2026 EPS of $0.69 exceeding expectations, while maintaining strong operational cash flow of $2.32B in 2025. Recent developments include FDA approval for WAKIX in Japan and continued recognition as a top employer.
Despite negative net margins, Viatris demonstrates improving cash flow trends and strategic portfolio optimization. The stock offers 27% upside to consensus price target of $22.17, though investors face risks from debt levels and competitive pressures in the generic drug market. Deleveraging progress and pipeline advancements support potential re-rating.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →